Contrast Comparison of CEUS and CECT or CEMRI in Assessment of Tumor Vascularity and Response to Thermal Ablation in Patients with Hepatocellular Carcinoma : A Multi-centre Study in China

L. Ming-de,Yuan Xiao-ling,Li An-hua,Tian-An Jiang,Min-hua Chen,Bao-zhen Zhao,Xiao-dong Zhou,Jin-rui Wang

2007-01-01

Abstract:Because ultrasound is simple, noninvasive and real-time, percutaneous radiofrequency ablation of hepatocellular carcinomas is usually performed under ultrasound guidance. However, it is often difficult to detect residue or recurrence after ablation. To solve the problem without spoiling the advantages, we developed Real-time Virtual Sonography (RVS). RVS was performed in 82 hepatocellular carcinoma patients before treatment. The MPR imaging of each target tumor was displayed under good synchronization with the ultrasound imaging in all the patients. Ablation was successfully performed in all the patients. RVS was useful for the identification of residual tumor or recurrent tumor after ablation and the selection of the target tumor among multiple nodular lesions. What guarantees the radical cure of the patient after radiofrequency ablation (RFA), is precise evaluation of treatment effect. The comparison of dynamic CT imaging between preand post-RFA is generally believed to be most reliable. The precise evaluation, however, is not as easy as generally believed. Difference of examination date and time makes subtle difference of the posture and respiratory status. Edema of the treated site and change of the tumor volume cause local deformation. Therefore, superimposing the post-RFA imaging onto the pre-RFA imaging is rarely possible. To synchronize each imaging easily and as precisely as possible, we developed Multi-window Realtime Virtual Sonography (MRVS). MRVS was performed in 21 hepatocellular carcinoma patients treated RFA. Each imaging synchronized well in all the patients. We could compare the preand post-RFA imaging from one end of the tumor to the other continuously. Subcostal and intercostal scanning, that is clinically familiar imaging, is easily demonstrated on the screen; the evaluation of treatment effect was achieved more precisely and accurately. Sonazoid that is a continuous enhancer different from Levovist can obtain real-time contrast imaging. Sonazoid enabled true Real-time Virtual Contrast Sonography. Now, we applied Sonazoid to MRVS. We obtained well-synchronized imaging that can call Easy-to-Understand Evidence-Based Imaging for Everyone. We present it with movie.